EMERALD ADVISERS, LLC – Supernus Pharmaceuticals, Inc. Transaction History
EMERALD ADVISERS, LLC portfolio value:
$10.61M
portfolio value
EMERALD ADVISERS, LLC quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +348.46% | 243.57K shares | 8.58M | $33.85 | 313.47K |
| Q2 2022 | share | Increase | 0.00% | 69.9K shares | 2.02M | $28.92 | 69.9K |
| Q1 2018 | share | Decrease | -100.00% | -552.94K shares | -22.03M | $45.8 | 0 |
| Q4 2017 | share | Decrease | -8.74% | -52.97K shares | -2.20M | $39.85 | 552.94K |
| Q3 2017 | share | Increase | +21.61% | 107.69K shares | 2.76M | $40 | 605.92K |
| Q2 2017 | share | Increase | 0.00% | 498.23K shares | 21.47M | $43.1 | 498.23K |